MedMesh.i
Curation
Accueil
Racine
Curation
Exploration
Accueil
Racine
Accueil

Gentilly AND (oncology OR urology) - Curation (Accueil)

Index « MedMesh.i » - tête de navigation
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Index : MedMesh.i

Pour accéder à une entrée :

Les termes de plus forte occurence

63Humans
36Female
36Aged
31Middle Aged
26Male
23Adult
15Antineoplastic Agents
15Aged, 80 and over
14Treatment Outcome
14Prospective Studies
14Antineoplastic Combined Chemotherapy Protocols
12Neoplasms
12Neoplasm Recurrence, Local
11Retrospective Studies
11Breast Neoplasms
10Neoplasm Metastasis
9Bevacizumab
8France
8Disease-Free Survival
7Survival Rate
7Ovarian Neoplasms
7Follow-Up Studies
6Young Adult
6Prostatic Neoplasms, Castration-Resistant
6Anemia
5Survival Analysis
5Recombinant Proteins
5Quality of Life
5Prognosis
5Disease Progression
5Combined Modality Therapy
5Cohort Studies
5Adenocarcinoma
4Surveys and Questionnaires
4Oxaliplatin
4Organoplatinum Compounds
4Hematinics
4Fluorouracil
4Clinical Trials as Topic
4Carcinoma, Ovarian Epithelial
4Adolescent
3Registries
3Receptor, ErbB-2
3Radiotherapy, Adjuvant
3Prostatectomy
3Proportional Hazards Models
3Platinum
3Paclitaxel
3Hemoglobins
3Hematologic Neoplasms
3Europe
3Erythropoietin
3Drug Administration Schedule
3Doxorubicin
3Child
3Chemotherapy, Adjuvant
3Chemoradiotherapy, Adjuvant
3Antineoplastic Agents, Immunological
3Animals
3Age Factors
2Vinblastine
2Urothelium
2Treatment Failure
2Trastuzumab
2Tomography, X-Ray Computed
2Time Factors
2Taxoids
2Tamoxifen
2Salvage Therapy
2Robotic Surgical Procedures
2Risk Factors
2Recurrence
2Rectal Neoplasms
2Prostatic Neoplasms
2Prostate-Specific Antigen
2Progression-Free Survival
2Practice Guidelines as Topic
2Polyethylene Glycols
2Pilot Projects
2Neoadjuvant Therapy
2Multivariate Analysis
2Mindfulness
2Meditation
2Medical Oncology
2Magnetic Resonance Imaging
2Lung Neoplasms
2Liver Neoplasms
2Leucovorin
2Irinotecan
2Incidence
2Immunotherapy
2Geriatric Assessment
2Ferritins
2Fatigue
2Everolimus
2Drug-Related Side Effects and Adverse Reactions
2Drug Resistance, Neoplasm
2Cross-Sectional Studies
2Colorectal Neoplasms
2Capecitabine
2Biomarkers, Tumor
2Biological Assay
2Antimetabolites, Antineoplastic
2Abiraterone Acetate
1ras Proteins
1Workload
1Vinorelbine
1Vascular Endothelial Growth Factor A
1Urologic Neoplasms
1Urinary Bladder Neoplasms
1Uracil
1Triple Negative Breast Neoplasms
1Transferrins
1Trabectedin
1Topotecan
1Thiophenes
1Telephone
1Telangiectasis
1Tegafur
1TOR Serine-Threonine Kinases
1Surgeons
1Sulfonamides
1Stomach Neoplasms
1Stakeholder Participation
1Solubility
1Skin
1Sirolimus
1Sex Cord-Gonadal Stromal Tumors
1Severity of Illness Index
1Serotonin Antagonists
1Sequence Analysis, DNA
1Sarcoma
1SARS-CoV-2
1Robotics
1Rituximab
1Retreatment
1Response Evaluation Criteria in Solid Tumors
1Research Design
1Remission Induction
1Recovery of Function
1Receptors, Estrogen
1Radiotherapy
1Radiosurgery
1Radiation-Sensitizing Agents
1Radiation Oncology
1Radiation Oncologists
1Radiation Injuries
1Quinazolines
1Pyrimidines
1Pyridines
1Proto-Oncogene Proteins
1Proto-Oncogene Proteins p21(ras)
1Proto-Oncogene Proteins c-akt
1Prostate
1Program Evaluation
1Private Sector
1Priapism
1Preoperative Care
1Prednisone
1Postoperative Complications
1Polymorphism, Single Nucleotide
1Platinum Compounds
1Physicians
1Phthalazines
1Phosphoproteins
1Phosphoinositide-3 Kinase Inhibitors
1Phosphatidylinositol 3-Kinases
1Phenylurea Compounds
1Pharmacology, Clinical
1Pharmaceutical Solutions
1Patient Selection
1Patient Preference
1Patient Education as Topic
1Patient Compliance
1Paresthesia
1Parents
1Pancreas, Artificial
1Ondansetron
1Oncology Service, Hospital
1Oncologists
1Nutrition Disorders
1Neoplasms, Second Primary
1Neoplasm Staging
1Neoplasm Grading
1Near Miss, Healthcare
1Multiprotein Complexes
1Multiple Myeloma
1Mothers
1Morpholines
1Mitomycin
1Mental Disorders
1Medical Overuse
1Mechanistic Target of Rapamycin Complex 1
1Maltose
1Male Urogenital Diseases
1Lymphoma, Non-Hodgkin
1Lymphedema
1Lymphatic Metastasis
1Lung
1Liver
1Length of Stay
1Kidney
1Kidney Diseases
1Ketones
1Kaplan-Meier Estimate
1Iron
1Iodine Radioisotopes
1Insulin Infusion Systems
1Injections, Subcutaneous
1Infusions, Intravenous
1Infant
1Infant, Newborn
1Indoles
1Indazoles
1Hypothalamic Neoplasms
1Hypertension
1Hospitals
1Heterocyclic Compounds
1Hemoglobin A
1Hematopoietic Stem Cell Mobilization
1Hematology
1Hematologic Diseases
1Heart
1Health Promotion
1Hamartoma
1Guideline Adherence
1Granulocyte Colony-Stimulating Factor
1Glucaric Acid
1Glioblastoma
1Genetic Profile
1Genes, BRCA2
1General Practitioners
1Gastrointestinal Diseases
1Furans
1Frailty
1Focus Groups
1Fibrosis
1Ferric Oxide, Saccharated
1Ferric Compounds
1Family
1Extremities
1Exercise
1Evidence-Based Medicine
1Estrogen Receptor alpha
1Esophagogastric Junction
1Esophagitis
1Erythrocyte Transfusion
1Equipment Design
1Epoetin Alfa
1Enhanced Recovery After Surgery
1Endometrial Neoplasms
1Emotions
1Elective Surgical Procedures
1Dyspnea
1Drug Synergism
1Drug Stability
1Drug Industry
1Drug Combinations
1Dose-Response Relationship, Drug
1Dogs
1Docetaxel
1Dietary Supplements
1Diabetes Mellitus, Type 2
1Dermatitis
1Depression
1Deoxycytidine
1Delivery of Health Care
1Data Interpretation, Statistical
1DNA Damage
1Cyclams
1Critical Pathways
1Confidence Intervals
1Comorbidity
1Clinical Trials, Phase II as Topic
1Clinical Trials, Phase I as Topic
1Clinical Competence
1Class I Phosphatidylinositol 3-Kinases
1Child, Hospitalized
1Cell Cycle Proteins
1Case-Control Studies
1Carcinoma
1Carcinoma, Renal Cell
1Carcinoma, Lobular
1Carcinoma, Endometrioid
1Carcinoma, Ductal, Breast
1Carbamazepine
1Cancer Survivors
1Camptothecin
1Cadaver
1COVID-19
1CA-125 Antigen
1Brachytherapy
1Bone Marrow
1Body Mass Index
1Blood Glucose
1Blood Glucose Self-Monitoring
1Biosimilar Pharmaceuticals
1Biomedical Research
1Biomarkers
1Benzylamines
1Bayes Theorem
1Base Sequence
1B-Lymphocytes
1Attitude of Health Personnel
1Aromatase Inhibitors
1Anxiety
1Antigens, CD34
1Antigens, CD20
1Antiemetics
1Antibodies, Monoclonal, Humanized
1Anthropometry
1Angiogenesis Inhibitors
1Anesthesia
1Androstadienes
1Androgen Antagonists
1Analysis of Variance
1Aminopyridines
1Ambulatory Care
1Alopecia
1Administration, Intravesical
1Administration, Intravenous
1Adjuvants, Immunologic
1Adaptor Proteins, Signal Transducing

Manipulations en shell (Unix/Dilib)

HfdCat GentillyOncoV1/Data/Main/Curation/MedMesh.i.hfd| SxmlCut idx/l | grep ...
Wicri

This area was generated with Dilib version V0.6.39.
Data generation: Thu Feb 8 07:40:56 2024. Site generation: Thu Feb 8 07:42:40 2024